A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors

Published:2021-08-29 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Kim Jin‐Ock¹,Kim Kwang‐Hyeok¹,Baek Eun Ji¹,Park Bomi¹,So Min Kyung²,Ko Byoung Joon³,Ko Han‐Jik⁴,Park Sang Gyu¹⁴^ORCID

Affiliation:

1. College of Pharmacy Ajou University Suwon‐si Korea

2. New Drug Development Center Osong Medical Innovation Foundation Korea

3. School of Biopharmaceutical and Medicinal Sciences Sungshin Women's University Seoul Korea

4. Novelty Nobility Seongnam‐si Korea

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13084

Reference77 articles.

1. Stem Cell Factor/c-kit Receptor Signaling Enhances the Proliferation and Invasion of Colorectal Cancer Cells Through the PI3K/Akt Pathway

2. The D816V Mutation of c-Kit Circumvents a Requirement for Src Family Kinases in c-Kit Signal Transduction

3. Stem Cell Factor and Hematopoiesis

4. Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications

5. The Aberrant Localization of Oncogenic Kit Tyrosine Kinase Receptor Mutants Is Reversed on Specific Inhibitory Treatment

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-tumor effect of antibody-drug conjugate targeting cell adhesion molecule 1 on GIST cells representing small intestinal GIST;Experimental and Molecular Pathology;2024-10

2. The immunotherapy in gastrointestinal stromal tumors;Heliyon;2024-07

3. Evaluation of drug sensitivity, immunological characteristics, and prognosis in melanoma patients using an endoplasmic reticulum stress-associated signature based on bioinformatics and pan-cancer analysis;Journal of Molecular Medicine;2023-08-31

4. Patent landscape of platelet growth factor receptor and c-KIT targets;Pharmaceutical Patent Analyst;2023-07

5. Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers;Molecular Cancer;2023-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3